Exicure board members Jiyoung Hwang and Paul Kang resign; Kang to provide consulting for 12 months

EXICURE, INC.

Jiyoung Hwang resigned from the Board on Feb 28, 2025 for personal reasons; no disagreement.
Paul Kang resigned from the Board effective March 3, 2025; will provide transitional consulting services for 12 months.
Consulting agreement with Kang executed on Feb 27, 2025; Kang previously served as co-CEO after Andy Yoo was appointed CEO on Dec 17, 2024.
Both resignations were not due to any disagreement with Company operations, policies, or practices.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Paul Kang

Director

XCUR · EXICURE, INC.

Effective: 2025-03-03
Filed: March 5, 2025, 6:59 PM ET

In conjunction with the execution of this consulting agreement, Mr. Kang resigned from the Board for personal reasons, effective as of March 3, 2025.

Departed

Jiyoung Hwang

Director

XCUR · EXICURE, INC.

Effective: 2025-02-28
Filed: March 5, 2025, 6:59 PM ET

On February 28, 2025, Jiyoung Hwang resigned from the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”) for personal reasons, effective immediately as of such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Kang resigned as Director at EXICURE, INC..

Action: resigned
Role: Director

Exact text from the filing

In conjunction with the execution of this consulting agreement, Mr. Kang resigned from the Board for personal reasons, effective as of March 3, 2025.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jiyoung Hwang resigned as Director at EXICURE, INC..

Action: resigned
Role: Director

Exact text from the filing

On February 28, 2025, Jiyoung Hwang resigned from the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”) for personal reasons, effective immediately as of such date.

View on SEC.gov

EXICURE, INC. filing history →

Source: SEC EDGAR

accession 0001628280-25-010535

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.